Ron Baron

Baron Capital

Ronald Stephen Baron is a prominent American mutual fund manager and the founder of Baron Capital, a New York City-based investment management firm. With a substantial influence in the investment community, Baron Capital focuses on long-term growth and value investing, managing approximately $49 billion in assets as of December 2025. Baron is known for his disciplined investment philosophy, emphasizing the importance of thorough research and a long-term perspective in stock selection. Baron Capital manages the Baron Funds, which are designed to achieve superior returns through a concentrated portfolio of high-quality growth companies. The firm's investment strategy revolves around identifying innovative businesses with strong management teams and sustainable competitive advantages, primarily in sectors such as technology, consumer cyclical, and healthcare. The disclosed trading record for Baron Capital reveals a dynamic approach with 200 reported transactions, including 53 position increases and 114 reductions. The firm's largest disclosed move involved trimming its position in Tesla Inc (TSLA) by approximately $927.7 million on May 15, 2026. This activity underscores a strategic adjustment in their portfolio as they navigate market conditions.

Latest Holdings

HoldingReported ValueWeightSharesLast PriceEst. ValueReturn
Terreno Realty Corporation (TRNO)TRNO · Q1 2026$4M0%67.5k$72.06$5M+17.3%
American Tower CorpAMT · Q1 2026$4M0%23.7k$168.92$4M-2.12%
92686J10692686J106 · Q1 2026$4M0%125.5k------
Teva Pharmaceutical Industries LimitedTEVA · Q1 2026$4M0%130k$31.18$4M+3.52%
Elanco Animal Health IncorporatedELAN · Q1 2026$4M0%163.5k$25.52$4M+6.64%
Essex Property Trust IncESS · Q1 2026$4M0%16.1k$293.20$5M+21.2%
SailPoint, Inc.SAIL · Q1 2026$4M0%292.6k$15.86$5M+19.8%
Veradermics, IncorporatedMANE · Q1 2026$4M0%59.7k$115.86$7M+83.5%
Clearwater Analytics Holdings, Inc.CWAN · Q1 2026$4M0%154.9k$24.56$4M+3.85%
9.2343E+1069.2343E+106 · Q1 2026$4M0%14.4k------
Roivant Sciences Ltd.ROIV · Q1 2026$3M0%125k$34.96$4M+26.2%
Ionis Pharmaceuticals, Inc.IONS · Q1 2026$3M0%45k$55.87$3M-25.6%
Vertex Pharmaceuticals IncorporatedVRTX · Q1 2026$3M0%7.5k$481.00$4M+7.72%
Natera, Inc.NTRA · Q1 2026$3M0%16.6k$265.25$4M+32.6%
2.8176E+1122.8176E+112 · Q1 2026$3M0%41.2k------
Fiverr International Ltd OrdinaryFVRR · Q1 2026$3M0%327.9k$11.64$4M+16.2%
Insmed IncorporatedINSM · Q1 2026$3M0%20k$106.64$2M-34.8%
Merck & Co., Inc.MRK · Q1 2026$3M0%25k$127.52$3M+6.01%
Guardant Health, Inc.GH · Q1 2026$3M0%32k$149.75$5M+62.1%
Palo Alto Networks, Inc.PANW · Q1 2026$3M0%17.9k$342.15$6M+113.4%
Voyager Technologies, Inc.VOYG · Q1 2026$3M0%120k$25.03$3M+7.01%
MADRIGAL PHARMACEUTICALS INCMDGL · Q1 2026$3M0%5.3k$537.65$3M+2.71%
84741088474108 · Q1 2026$3M0%13.4k------
American Homes 4 Rent Common Shares of Beneficial InterestAMH · Q1 2026$3M0%94k$34.34$3M+23%
Insulet Corp.PODD · Q1 2026$2M0%11.2k$167.65$2M-20.1%
Solaris Energy Infrastructure, Inc. Class A Common StockSEI · Q1 2026$2M0%39k$61.39$2M+8.64%
Palantir Technologies IncPLTR · Q1 2026$2M0%13k$135.78$2M-7.18%
Terns Pharmaceuticals, Inc.TERN · Q1 2026$2M0%35k$52.95$2M+0.44%
Stryker CorpSYK · Q1 2026$2M0%5.5k$320.64$2M-2.42%
Synopsys IncSNPS · Q1 2026$2M0%4.5k$378.46$2M-4.54%
AbbVie Inc.ABBV · Q1 2026$2M0%8k$253.30$2M+16.5%
Kymera Therapeutics, Inc.KYMR · Q1 2026$2M0%20k$113.99$2M+36.9%
7.4366E+1067.4366E+106 · Q1 2026$2M0%15k------
H D F C Bank LtdHDB · Q1 2026$2M0%63.3k$24.07$2M-3.26%
CYTOKINETICS INCCYTK · Q1 2026$2M0%23k$80.75$2M+22.5%
Morgan StanleyMS · Q1 2026$1M0%9.1k$216.42$2M+31.5%
Xenon Pharmaceuticals Inc.XENE · Q1 2026$1M0%25k$66.98$2M+15.2%
Bank of America CorpBAC · Q1 2026$1M0%28.2k$61.62$2M+26.4%
ASCENDIS PHARMA A/SASNDUSD · Q1 2026$1M0%5.6k------
03770N10103770N101 · Q1 2026$1M0%15k------
Douglas Emmett, Inc.DEI · Q1 2026$1M0%124.4k$12.13$2M+28.8%
Micron Technology IncMU · Q1 2026$1M0%3.3k$970.82$3M+187.4%
Capital One Financial Corporation Common StockCOF · Q1 2026$1M0%6k$201.36$1M+10.4%
BlackRock, Inc.BLK · Q1 2026$1M0%1.1k$1,063.03$1M+10.5%
M7518J104M7518J104 · Q1 2026$838k0%62.6k------
Henry (Jack) & Associates IncJKHY · Q1 2026$793k0%5k$148.23$744k-6.21%
Berkshire Hathaway Inc.BRK-A · Q1 2026$718k0%1$732,750.00$733k+2.03%
The Progressive CorpPGR · Q1 2026$684k0%3.5k$205.90$711k+3.86%
The Goldman Sachs Group IncGS · Q1 2026$677k0%800$1,072.80$858k+26.8%
Lattice Semiconductor CorporationLSCC · Q1 2026$676k0%7.3k$127.74$931k+37.7%
Showing 251-300 of 326